Attached files
| file | filename |
|---|---|
| EX-32.1 - ONCOLOGIX TECH, INC. AND SUBSIDIARIES - Oncologix Tech Inc. | oclg10qa11302013ex32_1.htm |
| EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - Oncologix Tech Inc. | oclg10qa11302013ex31_2.htm |
| 10-Q/A - OCLG10QA11302013 - Oncologix Tech Inc. | oclg10qa11302013.htm |
| EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - Oncologix Tech Inc. | oclg10qa11302013ex31_1.htm |
Exhibit 32.2
ONCOLOGIX TECH, INC. AND SUBSIDIARIES
CERTIFICATION OF PRINCIPAL
FINANCIAL OFFICER PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Oncologix Tech, Inc. (the “Company”) on Form 10-Q for the three months ended November 30, 2013, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I Michael A. Kramarz, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:
| (3) | The report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (4) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
| Date: March 31, 2014 | ONCOLOGIX TECH, INC. | |
| By | /s/ Michael A. Kramarz | |
| Name:
Michael A. Kramarz Title: Chief Financial Officer | ||